相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Anti-Diabetic Medications and Risk of Pancreatic Cancer in Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Serum insulin and C-peptide concentration and breast cancer: a meta-analysis
Philippe Autier et al.
CANCER CAUSES & CONTROL (2013)
Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors
Alexandra E. Butler et al.
DIABETES (2013)
Glargine safety, diabetes and cancer
Marc Rendell et al.
EXPERT OPINION ON DRUG SAFETY (2013)
Effect of type 2 diabetes on risk for malignancies includes hepatocellular carcinoma in chronic hepatitis C
Yasuji Arase et al.
HEPATOLOGY (2013)
The Role of Preexisting Diabetes Mellitus on Incidence and Mortality of Endometrial Cancer A Meta-Analysis of Prospective Cohort Studies
Zhi-Hua Zhang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Diabetes Mellitus and Ovarian Cancer Risk A Systematic Review and Meta-Analysis of Observational Studies
Jung-Yun Lee et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Effect of GLP1R agonists taspoglutide and liraglutide on primary thyroid C-cells from rodent and man
Franziska Boess et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2013)
Mammary tumor growth and pulmonary metastasis are enhanced in a hyperlipidemic mouse model
N. Alikhani et al.
ONCOGENE (2013)
Diabetes Mellitus and Risk of Bladder Cancer: A Meta-Analysis of Cohort Studies
Xin Xu et al.
PLOS ONE (2013)
Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth
Heather A. Hirsch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Pre-existing diabetes mellitus increases the risk of gastric cancer: A meta-analysis
Jae Moon Yoon et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Insulin glargine use and short-term incidence of breast cancer - a four-year population-based observation
Rickard Ljung et al.
ACTA ONCOLOGICA (2012)
Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies
Jorge J. Castillo et al.
BLOOD (2012)
The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells
Hagai Ligumsky et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Diabetes and breast cancer risk: a meta-analysis
P. Boyle et al.
BRITISH JOURNAL OF CANCER (2012)
Diabetes and cancer I: risk, survival, and implications for screening
Adedayo A. Onitilo et al.
CANCER CAUSES & CONTROL (2012)
Diabetes mellitus and the incidence and mortality of colorectal cancer: a meta-analysis of 24 cohort studies
W. Luo et al.
COLORECTAL DISEASE (2012)
Cholesterol and prostate cancer
Kristine Pelton et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
A Prospective Study of the Associations Between Treated Diabetes and Cancer Outcomes
Hsin-Chieh Yeh et al.
DIABETES CARE (2012)
Mortality After Incident Cancer in People With and Without Type 2 Diabetes Impact of metformin on survival
Craig J. Currie et al.
DIABETES CARE (2012)
Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million US Adults
Peter T. Campbell et al.
DIABETES CARE (2012)
Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study
R. Ruiter et al.
DIABETOLOGIA (2012)
The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression
David P. Rose et al.
ENDOCRINE-RELATED CANCER (2012)
Quantifying insulin receptor isoform expression in FFPE breast tumors
Sean C. Harrington et al.
GROWTH HORMONE & IGF RESEARCH (2012)
Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus
Chia-Hsuin Chang et al.
HEPATOLOGY (2012)
Statin Use and Reduced Cancer-Related Mortality
Sune F. Nielsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer
Sakshi Sikka et al.
PPAR RESEARCH (2012)
Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
Michael N. Pollak
CANCER DISCOVERY (2012)
Insulin Resistance and Atherosclerosis
Vasudevan A. Raghavan
HEART FAILURE CLINICS (2012)
Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study
Wegene Borena et al.
CANCER CAUSES & CONTROL (2011)
Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer
Patrick G. Morris et al.
CANCER PREVENTION RESEARCH (2011)
Long-term effects of insulin glargine on the risk of breast cancer
S. Suissa et al.
DIABETOLOGIA (2011)
Insulin X10 revisited: a super-mitogenic insulin analogue
B. F. Hansen et al.
DIABETOLOGIA (2011)
Glucagon-Like Peptide-1 Receptor Activation Inhibits Growth and Augments Apoptosis in Murine CT26 Colon Cancer Cells
Jacqueline A. Koehler et al.
ENDOCRINOLOGY (2011)
Diabetes Mellitus, Race and the Odds of High Grade Prostate Cancer in Men Treated With Radiation Therapy
Timur Mitin et al.
JOURNAL OF UROLOGY (2011)
The Metabolic Syndrome-from Insulin Resistance to Obesity and Diabetes
Emily Jane Gallagher et al.
MEDICAL CLINICS OF NORTH AMERICA (2011)
Smoking and Risk for Diabetes Incidence and Mortality in Korean Men and Women
Sun Ha Jee et al.
DIABETES CARE (2010)
Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?
P. C. Butler et al.
DIABETOLOGIA (2010)
Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas
J. S. Nachnani et al.
DIABETOLOGIA (2010)
Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation
Lotte Bjerre Knudsen et al.
ENDOCRINOLOGY (2010)
CAUSES OF DEATH IN MEN WITH PREVALENT DIABETES AND NEWLY DIAGNOSED HIGH- VERSUS FAVORABLE-RISK PROSTATE CANCER
Anthony V. D'Amico et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2010)
Does pre-existing diabetes affect prostate cancer prognosis? A systematic review
C. F. Snyder et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Angiogenesis, adipokines and breast cancer
Linda Vona-Davis et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2009)
Beneficial Endocrine but Adverse Exocrine Effects of Sitagliptin in the Human Islet Amyloid Polypeptide Transgenic Rat Model of Type 2 Diabetes Interactions With Metformin
Aleksey V. Matveyenko et al.
DIABETES (2009)
Combined randomised controlled trial experience of malignancies in studies using insulin glargine
P. D. Home et al.
DIABETOLOGIA (2009)
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study
J. Rosenstock et al.
DIABETOLOGIA (2009)
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden
J. M. Jonasson et al.
DIABETOLOGIA (2009)
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
H. M. Colhoun
DIABETOLOGIA (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
L. G. Hemkens et al.
DIABETOLOGIA (2009)
Insulin, Insulin-Like Growth Factor-I, and Risk of Breast Cancer in Postmenopausal Women
Marc J. Gunter et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
Jennifer H. Law et al.
CANCER RESEARCH (2008)
CD26/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1/CXCL12
Yan-Xi Sun et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages
Paola Allavena et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2008)
Rosiglitazone and risk of cancer - A meta-analysis of randomized clinical trials
Matteo Monami et al.
DIABETES CARE (2008)
Dipeptidyl peptidase IV (DPPIV), a candidate tumor suppressor gene in melanomas is silenced by promoter methylation
Carolyn McGuinness et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Andrew G. Renehan et al.
LANCET (2008)
Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies
Paola Pisani
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study
Gillian K. Reeves et al.
BRITISH MEDICAL JOURNAL (2007)
Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition
Mazda Jenab et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition
Anne E. Cust et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes
Rangaswamy Govindarajan et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation
KGMM Alberti et al.
DIABETIC MEDICINE (2006)
The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
HB El-Serag et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events):: a randomised controlled trial
JA Dormandy et al.
LANCET (2005)
Type-II diabetes and pancreatic cancer:: a meta-analysis of 36 studies
R Huxley et al.
BRITISH JOURNAL OF CANCER (2005)
Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk
ES Schernhammer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
A prospective study of plasma C-peptide and colorectal cancer risk in men
J Ma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Fasting insulin and outcome in early-stage breast cancer: Results of a prospective cohort study
PJ Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women
R Kaaks et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
